1. Home
  2. LII vs BBIO Comparison

LII vs BBIO Comparison

Compare LII & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lennox International Inc.

LII

Lennox International Inc.

HOLD

Current Price

$506.58

Market Cap

15.8B

Sector

Industrials

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$74.66

Market Cap

15.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LII
BBIO
Founded
1895
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8B
15.3B
IPO Year
1999
2019

Fundamental Metrics

Financial Performance
Metric
LII
BBIO
Price
$506.58
$74.66
Analyst Decision
Hold
Strong Buy
Analyst Count
12
25
Target Price
$569.45
$86.04
AVG Volume (30 Days)
386.1K
1.5M
Earning Date
04-29-2026
04-28-2026
Dividend Yield
1.06%
N/A
EPS Growth
1.11
N/A
EPS
22.79
N/A
Revenue
$5,195,300,000.00
$502,076,000.00
Revenue This Year
$6.90
$88.16
Revenue Next Year
$5.73
$74.13
P/E Ratio
$21.50
N/A
Revenue Growth
N/A
126.26
52 Week Low
$434.06
$31.77
52 Week High
$689.44
$84.94

Technical Indicators

Market Signals
Indicator
LII
BBIO
Relative Strength Index (RSI) 58.67 57.26
Support Level $481.66 $70.65
Resistance Level $532.29 $78.20
Average True Range (ATR) 17.46 2.54
MACD 6.49 0.48
Stochastic Oscillator 97.76 81.78

Price Performance

Historical Comparison
LII
BBIO

About LII Lennox International Inc.

Lennox International manufacturers and distributes heating, ventilating, air conditioning, and refrigeration products for the North American replacement (75% of sales) and new construction (25% of sales) markets. Residential HVAC (home comfort solutions) accounted for 67% of sales and commercial HVAC (building climate solutions) accounted for the remaining 33% of sales. To be clear, Lennox's commercial exposure is what its peers refer to as "residential and light commercial," lacks the scale and complexity of what is referred to as an "applied" solution. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: